Skip to main content

6568 · KNC Laboratories Co., Ltd. · Financials

1,189 JPY +13 (+1.11%) At close · Nov 12
Market Cap
9.20B JPY
Shares
7.74M
Volume · Nov 12 6000 Avg daily vol (3M) 3911

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
9.09B +11.2%
FY2026 Revenue FY2022–FY2026
Net Income
766.2M +3.9%
FY2026 Net Income FY2022–FY2026
Gross Margin
26.26% -2.1pp
FY2026 Gross Margin FY2022–FY2026
Operating Margin
11.27% +1.8pp
FY2026 Operating Margin FY2022–FY2026
Operating Cash Flow
2.26B +52.1%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 FY2025 FY2024 FY2023 FY2022
JPY 9.09B 8.18B 9.15B 8.63B 7.44B
JPY 6.71B 5.86B 5.86B 5.32B 5.33B
JPY 2.39B 2.32B 3.3B 3.3B 2.11B
JPY 1.02B 771.86M 2.08B 2.16B 1.09B
JPY 1.03B 927.99M 2.09B 2.17B 916.77M
JPY 259.63M 190.66M 600.16M 629.52M 273.3M
JPY 766.2M 737.33M 1.49B 1.54B 643.46M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 1.21B in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.